A combination of three breast cancer drugs could prolong the life of some women by more than one year.
Ibrance, which is manufactured by Pfizer, is an experimental treatment for advanced breast cancer.
Triple negative breast cancer accounts for 15 to 20-percent of all breast cancers and strikes younger women more than other forms of the disease.
A new study reveals many breast cancer patients don't know enough about their condition.
Eating a low-fat diet may reduce the risk of early death in some women with breast cancer.
According to a new study, early stage breast cancer patients may be receiving longer courses of radiation than necessary.
Two preliminary studies into medications under development may offer some hope for women with advanced breast cancer.
New research shows male and female breast cancer differ from each other.
A new study out this morning suggests many elderly women are getting breast cancer treatment that may not help in the long run.
The 3-d mammograms not only reduced the need for additional screenings or biopsies but also fewer tests in turn helped reduce patient anxiety.